Arbutus Biopharma (ABUS) Stock Chart & Stock Price History $3.40 +0.05 (+1.49%) Closing price 04:00 PM EasternExtended Trading$3.41 +0.01 (+0.29%) As of 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Arbutus Biopharma Stock Price Performance The Arbutus Biopharma (ABUS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 6.08%, with a year-to-date return of 3.98%. In the past month, the stock has increased 7.26%, reflecting recent market activity. As of the latest close, Arbutus Biopharma traded at $3.35 with a market cap of $642.20 million and volume of 422,144 shares. Five years ago, the stock traded at $3.44, representing a 1.16% decrease over that period. At the time, it had a market cap of $296.13 million and a volume of 13.33 million shares. Receive ABUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+7.26%3 Month Performance+1.49%Year-To-Date Performance+3.98%1 Year Performance-6.08%5 Year Performance-1.16% ABUS Stock Chart for Tuesday, August, 12, 2025 ABUS Chart by TradingView Arbutus Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/12/2025$3.35$3.40+1.49%$3.41$3.33641,816 shs$651.78 million08/11/2025$3.40$3.35-1.47%$3.43$3.34422,144 shs$642.20 million08/08/2025$3.40$3.40$3.43$3.35637,103 shs$651.20 million08/07/2025$3.47$3.40-2.02%$3.54$3.31589,899 shs$651.19 million08/06/2025$3.41$3.47+1.76%$3.55$3.331.29 million shs$664.61 million08/05/2025$3.34$3.41+2.10%$3.42$3.30942,410 shs$653.12 million08/04/2025$3.27$3.34+2.14%$3.36$3.26521,514 shs$639.70 million08/01/2025$3.28$3.27-0.30%$3.39$3.27553,477 shs$626.30 million07/31/2025$3.30$3.28-0.61%$3.37$3.26730,633 shs$628.21 million07/30/2025$3.30$3.30$3.42$3.29616,617 shs$632.05 million Get the Latest News and Ratings for ABUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter. 07/29/2025$3.35$3.30-1.49%$3.40$3.30456,725 shs$632.05 million07/28/2025$3.22$3.35+4.04%$3.40$3.25764,076 shs$641.62 million07/25/2025$3.24$3.22-0.62%$3.26$3.20420,855 shs$616.72 million07/24/2025$3.23$3.24+0.31%$3.30$3.21464,889 shs$620.56 million07/23/2025$3.15$3.23+2.54%$3.26$3.13614,322 shs$618.64 million07/22/2025$3.14$3.15+0.32%$3.17$3.12410,421 shs$603.31 million07/21/2025$3.13$3.14+0.32%$3.18$3.11485,859 shs$601.40 million07/18/2025$3.14$3.13-0.32%$3.19$3.08894,105 shs$599.49 million07/17/2025$3.13$3.14+0.32%$3.20$3.12773,427 shs$601.40 million07/16/2025$3.13$3.13$3.16$3.101.07 million shs$599.48 million07/15/2025$3.24$3.13-3.40%$3.25$3.12569,267 shs$599.49 million07/14/2025$3.17$3.24+2.21%$3.25$3.14660,576 shs$620.56 million07/11/2025$3.28$3.17-3.35%$3.26$3.101.12 million shs$607.15 million Related Companies GMTX Stock Price Chart XENE Stock Price Chart OGN Stock Price Chart AMRX Stock Price Chart NAMS Stock Price Chart KNSA Stock Price Chart RXRX Stock Price Chart ARWR Stock Price Chart BLTE Stock Price Chart IDYA Stock Price Chart Receive ABUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABUS) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThis New Rule Could Change EverythingA new rule taking effect this September has Big Banks shifting billions into one asset they now treat like cas...American Alternative | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arbutus Biopharma Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Arbutus Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access